APA (7th ed.) Citation

Mohaupt, P., Pons, M., Vialaret, J., Delaby, C., Hirtz, C., & Lehmann, S. (2022). β-Synuclein as a candidate blood biomarker for synaptic degeneration in Alzheimer’s disease. BMC.

Chicago Style (17th ed.) Citation

Mohaupt, Pablo, Marie-Laure Pons, Jérôme Vialaret, Constance Delaby, Christophe Hirtz, and Sylvain Lehmann. β-Synuclein as a Candidate Blood Biomarker for Synaptic Degeneration in Alzheimer’s Disease. BMC, 2022.

MLA (9th ed.) Citation

Mohaupt, Pablo, et al. β-Synuclein as a Candidate Blood Biomarker for Synaptic Degeneration in Alzheimer’s Disease. BMC, 2022.